Video

Multidisciplinary Approach in Muscle-Invasive Bladder Cancer

For High-Definition, Click

A team-based approach that includes input from a surgeon and medical oncologist is essential for patients with muscle-invasive bladder cancer, Dean F. Bajorin, MD, notes. A multidisciplinary approach in the treatment of muscle-invasive bladder cancer appears to increase the percentage of patients receiving neoadjuvant cisplatin-based chemotherapy, according to study.

In some situations, patients may not receive treatment due to comorbidities; however, in many situations, neoadjuvant chemotherapy may not be administered simply due to a lack of education on the topic, Evan Y. Yu, MD, mentions. Data from experiences at the Thomas Jefferson University have demonstrated that the multidisciplinary approach results in better outcomes in patients with prostate cancer, moderator Daniel P. Petrylak, MD. This finding is pertinent for the integration of multidisciplinary approaches into evolving managed care and payment models.

Related Videos
Tiago Biachi, MD, PhD
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health
Alberto Montero, MD, MBA, CPHQ
Thomas Westbrook, MD, assistant professor, Rush University Medical Center
Alan Tan, MD, Vanderbilt-Ingram Cancer Center
Chad Tang, MD
Martin H. Voss, MD
Martin H. Voss, MD
Alexandra Drakaki, MD, PhD
Toni Choueiri, MD, director, Lank Center for Genitourinary Oncology, co-leader, kidney cancer program, Dana-Farber Cancer Institute; Jerome and Nancy Kohlberg Chair, professor, medicine, Harvard Medical School